BOT 8.70% 31.5¢ botanix pharmaceuticals ltd

Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-3

  1. 761 Posts.
    lightbulb Created with Sketch. 887
    Difficult to believe that BOT is the only play progressing clinical trials for derma based CBD applications........eek.png


    "Only 1 trial in dermatology(Botanix)" 


    "Botanix holds the exclusive rights to utilise Permetrex for all drugs that treat skin diseases".........."Permetrex™ technology enables superior delivery of cannabidiol"........


    Seriously looking forward to seeing these trial results........and very much awaiting some positive news re the possible functionality of the antimicrobial BTX1801....


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
31.5¢
Change
-0.030(8.70%)
Mkt cap ! $570.1M
Open High Low Value Volume
34.5¢ 34.5¢ 31.5¢ $6.354M 19.19M

Buyers (Bids)

No. Vol. Price($)
13 286322 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 28500 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.